Todd Alfred Carter insider trades

Open-market stock purchases and sales by Todd Alfred Carter, Chief Scientific Officer at Voyager Therapeutics, Inc, from SEC Form 4 filings since Sep 19, 2022.

Recent trades

DateStockTradeValue
Feb 24, 2026VYGR Voyager Therapeutics, IncSold$15.7K
Feb 18, 2026VYGR Voyager Therapeutics, IncSold$11.4K
Feb 10, 2026VYGR Voyager Therapeutics, IncSold$13.6K
Feb 6, 2026VYGR Voyager Therapeutics, IncBought (not open market)—
Feb 6, 2026VYGR Voyager Therapeutics, IncBought (not open market)—

Companies traded

  • VYGR Voyager Therapeutics, Inc: 18 sales, last Feb 24, 2026

Get free alerts when Todd Alfred Carter files a new trade →